Novartis UK is aware of concerns relating to stock of Tegretol Prolonged Release 200mg tablets. We confirm that supply is back in line with demand.
Outstanding stock issues across the range, caused by fluctuating demand and therefore short-term delays in manufacturing capabilities, have been addressed through increased manufacturing capacity. We have also contacted our wholesalers to ensure they have the stock they need so that supply is now back in line with demand.
We have notified the Association of British Pharmaceutical Industries (ABPI) and the Department of Health and Social Care (DHSC) of the concerns raised to us.
Our patients and customers are our number one priority and we aim to ensure a fair and equitable access to our medicines, for patients in need, no matter where they are and what their background.
If you are a healthcare professional and would like further information, please contact the Novartis Pharmaceuticals UK Medical Information Services by email ([email protected]) or by phone (+44 1276 698370).